期刊文献+

EDOP方案治疗复发难治性恶性淋巴瘤45例分析 被引量:1

Treatment of refractory or relapsing malignant lymphoma with EDOP regimens:a report of 45 cases
下载PDF
导出
摘要 目的:观察EDOP方案治疗复发难治性恶性淋巴瘤的疗效和毒副作用。方法:对45例复发难治性恶性淋巴瘤患者采用EDOP联合化疗方案进行治疗。结果:EDOP联合化疗方案有效率为(CR+PR)71.1%,完全缓解率(CR)为33.3%,部分缓解(PR)37.8%。主要不良反应为骨髓抑制和胃肠道反应。结论:EDOP方案治疗难治性或复发性恶性淋巴瘤有效率高,毒副反应低,值得进一步研究和推广。 Objective To evaluate the effects and side-effects of EDOP regimens of refractory or relapsing malignant lymphoma. Method 45 patients with refractory or relapsing malignant lymphoma were treated with EDOP regimens. Results The overall response rate was 71.1%, the rate of complete remission was 33.3%, the rate of partial remission was 37.8%.Main toxicities were neutropem and gastrointestinal side effects. Conclusion EDOP regimen has high effects and is safe in treatment of refractory or relapsing malignant lymphoma.
作者 鲍慧铮 程颖
机构地区 吉林省肿瘤医院
出处 《吉林医学》 CAS 2006年第1期47-48,共2页 Jilin Medical Journal
基金 吉林省科技发展计划项目资助(20030543-2)
关键词 EDOP方案 恶性淋巴瘤 复发 EDOP regimens malignant lymphoma
  • 相关文献

参考文献7

  • 1石远凯.努力提高恶性淋巴瘤规范化治疗的水平[J].中华内科杂志,2002,41(6):361-362. 被引量:7
  • 2Fisher RI,Gaynor ER,Dahlberg S,et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin lymphoma [J]. N Engl J Med, 1993; 328: 1002.
  • 3Canellos GP, Anderson JR, Propert KJ, et al.Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD [J]. N Engl J Med,1992;327:1478.
  • 4Ezzat A A,Khalifa F,Berry J,et al.ESHAP:an effective treatment in selected patients with relapsed non-Hodgkin's lymphoma [J]. Ann Oncol, 1994; 5:45.
  • 5Longo DL,Devita VT JR,Duffey PL,et al. Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma:results of prospective randomized trial[J]. J Clin Onco1,1991;9:25.
  • 6Connors JM,Klimo P. MACOP-B chemotherapy for malignant lymphomas and related conditions:1987 update and additional observations [J]. Semin Hematol, 1988; 25: 41.
  • 7Klimo P,Connors JM. MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma [J]. Ann Intern Med,1985; 102: 596.

二级参考文献8

  • 1Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood, 1994, 84: 1361-1392.
  • 2Specht L, Gray RJ, Clarke MJ, et al. Influence of more extensive radiotherapy, and adjuvant chemotherapy on long-term outcome of early stage Hodgkin′s disease: a meta-analysis of 23 randomized trials involving 3 888 patients. international Hodgkin′s disease Collaborative Group. J Clin Oncol,1998,16:830-843.
  • 3Duggan D, Petroni G, Johnson J, et al. MOPP/ABV versus ABVD for advanced Hodgkin′s disease - a preliminary report of CALGB 8952 (with SWOG, ECOG, NCIC). Proc Am Soc Clin Oncol, 1997,16:13a.
  • 4Connors JM, Chemotherapy for Hodgkin′s lymphoma: Is ABVD the gold standard? New Orleans: ASH, 1999. 277-280.
  • 5Shipp MA, Harrington DP, Anderson JR,et al. A predictive model for aggressive non-Hodgkin′s lymphoma. N Engl J Med,1993,329:987-994.
  • 6Nissen NI, Nordentoft AM. Radiotherapy versus combined modality treatment of stage Ⅰ and Ⅱ Hodgkin′s disease. Cancer Treat Rep, 1982,66:799-803.
  • 7Fisher RI,Gaynor ER, Dahlberg S, et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin′s lymphoma. N Engl J Med, 1993,328:1002-1006.
  • 8王奇璐,周立强,何小慧,顾大中,王宏羽,冯奉仪,石远凯,周爱萍,董梅,王子平,孙燕.非霍奇金淋巴瘤935例临床分析[J].中华肿瘤杂志,1999,21(2):153-155. 被引量:15

共引文献6

同被引文献11

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部